The National Agency for Food and Drug Administration and Control (NAFDAC) has warned healthcare providers and the public about the ...

The Food and Drug Administration has approved the combination of Lonsurf and Avastin for patients with metastatic colorectal cancer previously treated with chemotherapies, an anti-VEGF therapy and, if ...

Fatal side effects were 1.5 times more frequent among patients on Avastin plus chemotherapy than among those getting chemotherapy alone.The highest risk was seen in patients with prostate and lung ...

Adding Imfinzi and Avastin to transarterial chemoembolization led to a 23% reduction in the risk of progression or death in patients with liver cancer. Patients with unresectable hepatocellular ...

GAITHERSBURG, Maryland (Reuters) - A U.S. panel dealt a blow to Roche Holding AG's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. officials to revoke the medicine's approval for ...

CHICAGO • A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for ...

CHICAGO, June 6 (Reuters) - Long-term use of Swiss drugmaker Roche Holding AG's Avastin, in combination with chemotherapy, helped women with advanced ovarian cancer live longer without their cancer ...